• +353-1-415-1241(GMT OFFICE HOURS)
  • 1-800-526-8630(US/CAN TOLL FREE)
  • 1-917-300-0470(EST OFFICE HOURS)
Global Anesthesia Drugs Market 2012-2016 - Product Image

Global Anesthesia Drugs Market 2012-2016

  • Published: December 2012
  • Region: Global
  • 41 pages
  • TechNavio

TechNavio's analysts forecast the Global Anesthesia Drugs market to grow at a CAGR of 2.53 percent over the period 2012-2016. One of the key factors contributing to this market growth is the rise in the number of emergency surgeries. The Global Anesthesia Drugs market has also been witnessing the pediatrics applications of anesthesia. However, the allergic reactions in anesthesia could pose a challenge to the growth of this market.

TechNavio's report, the Global Anesthesia Drugs Market 2012-2016, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the Americas, and the EMEA and APAC regions; it also covers the General Anesthesia Drugs market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

The key vendors dominating the Anesthesia Drugs market space are Abbott Laboratories, AstraZeneca PLC, and Baxter International Inc.

The other vendors mentioned in the report are Celgene Corporation, Claris Life Sciences, Eisai Co. Ltd., Endo Pharmaceuticals Inc., Halocarbon Products Corp., Hospira Inc., Merck and Co., Piramal Healthcare, READ MORE >

01. Executive Summary
02. Introduction
03. Market Coverage
Market Overview
Product Offerings
04. Market Landscape
04.1 Global Anesthesia Drugs Market
Market Size and Forecast
04.2 Anesthesia Drugs Market in the US
Market Size and Forecast
04.3 Product Segmentation
04.4 Routes of Administration of Anesthesia Drugs
04.5 Major Anesthesia Products
04.6 Five Forces Analysis
05. Geographical Segmentation
06. Vendor Landscape
07. Buying Criteria
08. Market Growth Drivers
09. Drivers and their Impact
10. Market Challenges
11. Impact of Drivers and Challenges
12. Market Trends
13. Key Vendor Analysis
13.1 Abbott Laboratories
Business Overview
Key Information
SWOT Analysis
13.2 AstraZeneca plc
Business Overview
Key Information
SWOT Analysis
13.3 Baxter International Inc.
Business Overview
Key Information
SWOT Analysis
14. Other Reports in this Series

List of Exhibits:
Exhibit 1: Global Anesthesia Drugs Market 2012-2016 (US$ million)
Exhibit 2: Anesthesia Drugs Market in the US 2012-2016 (US$ million)
Exhibit 3: Global Anesthesia Drugs Market by Product Segmentation
Exhibit 4: Global Anesthesia Drugs Market by Product Segmentation 2012
Exhibit 5: Anesthesia Drugs: Routes of Administration
Exhibit 6: Routes of Administration of Anesthesia Drugs by Segmentation 2012
Exhibit 7: Global Anesthesia Drugs Market by Geographical Segmentation 2012
Exhibit 8: Global Anesthesia Drugs Market by Vendor Segmentation 2012
Exhibit 9: Business Segmentation of Abbott Laboratories
Exhibit 10: Business Segmentation of AstraZeneca plc

TechNavio Announces the Publication of its Research Report - Global Anesthesia Drugs Market 2012-2016

TechNavio today launched its report, Global Anesthesia Drugs Market 2012-2016, based on an in-depth analysis covering the Americas, and the EMEA and APAC regions. The report aims to aid decision makers' understanding of the present and future landscape of the market.

Commenting on the report, an analyst from TechNavio's Healthcare team said: ''Earlier, vendors manufactured gender-neutral anesthesia drugs. Nowadays, sex-based anesthesia drugs are being introduced into the market to address the concerns related to perioperative anesthetic care for both sexes. This trend has a strong impact on the market.''

According to the report, one of the main drivers in this market is the increasing aging population across the world. The aging population across the world is expected to increase massively by 2050. This increase in the aging population results in increased surgeries, which in turn leads to increased use of anesthesia drugs. Thus, the growing aging population across the world propels the growth of the Global Anesthesia Drugs market.

Further, the report reveals that one of the major challenges in this market is the presence of several regulations for anesthesia drugs.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to a SWOT analysis of the key vendors.

Abbott Laboratories, AstraZeneca PLC, Baxter International, Celgene Corporation, Claris Life Sciences, Eisai Co., Endo Pharmaceuticals, Halocarbon Products, Hospira, Merck & Co., Piramal Healthcare, Roche Diagnostics

Note: Product cover images may vary from those shown

RELATED PRODUCTS

Our Clients

Our clients' logos